Last update July 30, 2022

4-Carboxyl-4-(N-phenylpropionamido)-1-piperidine propionic acid dimethyl ester monohydrate

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Opioid analgesic related to fentanyl used in the induction and maintenance of general anesthesia, in postoperative analgesia and in local or regional anesthesia. intravenous administration.

Since the last update we have not found published data on its excretion in breastmilk.

Although its pharmacokinetic data (low molecular weight, low protein binding, high lipid solubility and low volume of distribution) make easy the passage into breast milk, its very short half-life (less than 10 minutes) makes its excretion in breast milk unlikely.  

No problems have been observed in breastfed infants aged 3 to 5 months whose mothers received remifentanil, propofol, rocuronium, and xenon for anesthesia for surgical procedures. (Stuttman 2010)

There were no significant differences in breastfeeding initiation, continuation, or problems between the groups of mothers treated with pethidine, meperidine, or remifentanil. (Moran 2019, Evron 2005)

The mother may breastfeed the baby as soon as she is recovered from anesthesia. No need to express and discard breast milk. (Reece 2017)

 

Expert authors consider the use of this medication to be probably safe during breastfeeding. (Hale, LactMed, Briggs 2015, Schaefer 2015, Howie 2006)

Alternatives

  • Fentanyl (Safe substance and/or breastfeeding is the best option.)
  • Ibuprofen (Safe substance and/or breastfeeding is the best option.)
  • Paracetamol (Safe substance and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

4-Carboxyl-4-(N-phenylpropionamido)-1-piperidine propionic acid dimethyl ester monohydrate is Remifentanil Hydrochloride in Chemical name.

Is written in other languages:

Group

4-Carboxyl-4-(N-phenylpropionamido)-1-piperidine propionic acid dimethyl ester monohydrate belongs to this group or family:

Tradenames

Main tradenames from several countries containing 4-Carboxyl-4-(N-phenylpropionamido)-1-piperidine propionic acid dimethyl ester monohydrate in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. Baja / Low %
Molecular weight 413 daltons
Protein Binding 70 %
VD 0.005 l/Kg
0.05 - 0.17 hours

References

  1. LactMed. Drugs and Lactation Database (LactMed). Internet. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/ 2006 - Consulted on April 16, 2024 Full text (link to original source)
  2. Hale TW. Medications & Mothers' Milk. 1991- . Springer Publishing Company. Available from https://www.halesmeds.com Consulted on April 10, 2024 Full text (link to original source)
  3. Moran VH, Thomson G, Cook J, Storey H, Beeson L, MacArthur C, Wilson M. Qualitative exploration of women's experiences of intramuscular pethidine or remifentanil patient-controlled analgesia for labour pain. BMJ Open. 2019 Dec 23;9(12):e032203. Abstract Full text (link to original source)
  4. Reece-Stremtan Sarah, Campos Matilde, Kokajko Lauren, and The Academy of Breastfeeding Medicine. Breastfeeding Medicine. ABM Clinical Protocol #15: Analgesia and Anesthesia for the Breastfeeding Mother, Revised 2017. Breastfeed Med. 2017 Nov;12(9):500-506. Full text (link to original source) Full text (in our servers)
  5. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Wolters Kluwer Health. Tenth edition (acces on line) 2015
  6. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation. Treatment options and risk assessment. Elsevier, Third Edition. 2015
  7. Dalal PG, Bosak J, Berlin C. Safety of the breast-feeding infant after maternal anesthesia. Paediatr Anaesth. 2014 Abstract
  8. Reynolds F. Labour analgesia and the baby: good news is no news. Int J Obstet Anesth. 2011 Abstract
  9. Stuttmann R, Schäfer C, Hilbert P, Meyer MR, Maurer HH. The breast feeding mother and xenon anaesthesia: four case reports. Breast feeding and xenon anaesthesia. BMC Anesthesiol. 2010 Abstract Full text (link to original source) Full text (in our servers)
  10. Howie WO, McMullen PC. Breastfeeding problems following anesthetic administration. J Perinat Educ. 2006 Abstract Full text (link to original source) Full text (in our servers)
  11. Evron S, Glezerman M, Sadan O, Boaz M, Ezri T. Remifentanil: a novel systemic analgesic for labor pain. Anesth Analg. 2005 Jan;100(1):233-238. Abstract

Total visits

534

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM